[HTML][HTML] An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory …

J Yamauchi, N Araya, N Yagishita, T Sato… - Pharmacology & …, 2021 - Elsevier
Human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a rare inflammatory disease causing unremitting and progressive …

[HTML][HTML] CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis

T Sato, A Coler-Reilly, A Utsunomiya… - PLoS neglected …, 2013 - journals.plos.org
Background Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) is a rare chronic neuroinflammatory disease. Since the …

[HTML][HTML] Proposal of classification criteria for HTLV-1-associated myelopathy/tropical spastic paraparesis disease activity

T Sato, N Yagishita, K Tamaki, E Inoue… - Frontiers in …, 2018 - frontiersin.org
Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a rare chronic neuroinflammatory disease. While the disease …

[HTML][HTML] Cerebrospinal fluid CXCL10 as a candidate surrogate marker for HTLV-1-associated myelopathy/tropical spastic paraparesis

K Tamaki, T Sato, J Tsugawa, S Fujioka… - Frontiers in …, 2019 - frontiersin.org
Human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a debilitating, progressive disease without effective treatment; …

[HTML][HTML] Lessons from the cerebrospinal fluid analysis of HTLV-1-infected individuals: biomarkers of inflammation for HAM/TSP development

NL Freitas, YCP Gomes, FS Souza, RC Torres… - Viruses, 2022 - mdpi.com
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a
neurodegenerative disease that leads to motor impairment due to a chronic inflammatory …

[HTML][HTML] Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Y Enose-Akahata, S Jacobson - Retrovirology, 2019 - Springer
Human T cell lymphotropic virus 1 (HTLV-1) is a human retrovirus and infects approximately
10–20 million people worldwide. While the majority of infected people are asymptomatic …

HTLV-1-associated myelopathy/tropical spastic paraparesis

CRM Bangham, A Araujo, Y Yamano… - Nature reviews Disease …, 2015 - nature.com
Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) is a progressive disease of the CNS that causes weakness or paralysis of the …

[HTML][HTML] Neuroimmunology of human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis

S Nozuma, S Jacobson - Frontiers in microbiology, 2019 - frontiersin.org
Human T-lymphotropic virus type 1 (HTLV-1) is the etiologic agent of both adult T-cell
leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis …

[HTML][HTML] Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis

Y Yamano, T Sato - Frontiers in microbiology, 2012 - frontiersin.org
Human T-lymphotropic virus type 1 (HTLV-1), a human retrovirus, is the causative agent of a
progressive neurological disease termed HTLV-1-associated myelopathy/tropical spastic …

Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy

U Oh, S Jacobson - Neurologic clinics, 2008 - Elsevier
The treatment of HAM/TSP is a challenge. No agent has shown to significantly modify the
long-term disability associated with HAM/TSP. Advances in our understanding of the …